A Study of Selinexor, in Combination With Carfilzomib, Daratumumab or Pomalidomide in Patients With Multiple Myeloma
Clinical trial NCT04661137 · SUSPENDED
Trial details
- NCT number
- NCT04661137
- Sponsor
- Hackensack Meridian Health
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-16
- Primary completion
- 2027-02-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.